X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
immunotherapy (9) 9
index medicus (6) 6
gene therapy (5) 5
immunogenic cell death (5) 5
immunogenic cell-death (5) 5
oncology (5) 5
cancer (4) 4
immune response (4) 4
immunology (4) 4
review (4) 4
animals (3) 3
antigens (3) 3
apoptosis (3) 3
biotechnology & applied microbiology (3) 3
cell death (3) 3
cytotoxic t lymphocytes (3) 3
dendritic cells (3) 3
gm-csf (3) 3
herpes-simplex-virus (3) 3
humans (3) 3
lymphocytes (3) 3
mice (3) 3
mice, inbred c57bl (3) 3
neoplasms. tumors. oncology. including cancer and carcinogens (3) 3
vesicular stomatitis-virus (3) 3
adenovirus (2) 2
antitumor activity (2) 2
antitumor immunity (2) 2
cancer therapies (2) 2
cd8-positive t-lymphocytes - immunology (2) 2
colony-stimulating factor (2) 2
cytokines (2) 2
female (2) 2
gene-therapy (2) 2
genetic aspects (2) 2
hsvtk suicide gene (2) 2
il-2 (2) 2
immune system (2) 2
immunogenic (2) 2
immunogenicity (2) 2
in-vivo (2) 2
infections (2) 2
kinases (2) 2
medical research (2) 2
medicine, research & experimental (2) 2
melanoma (2) 2
metastasis (2) 2
neoplasm metastasis (2) 2
neoplasm transplantation (2) 2
newcastle-disease virus (2) 2
non-immunogenic (2) 2
oncolytic (2) 2
proteins (2) 2
reolysin (2) 2
semliki-forest-virus (2) 2
thymidine kinase - genetics (2) 2
tumor cells (2) 2
tumor-cells (2) 2
tumors (2) 2
viruses (2) 2
4t1 mammary tumor (1) 1
4ti mammary tumor (1) 1
abscopal effect (1) 1
activation (1) 1
addiction (1) 1
adenoviridae - genetics (1) 1
adjuvant temozolomide (1) 1
adoptive immunotherapy (1) 1
adoptive t cell therapy (1) 1
adoptive transfer (1) 1
animals; antiviral agents/therapeutic use; cd8-positive t-lymphocytes/immunology; cd8-positive t-lymphocytes/metabolism; combined modality therapy; female; ganciclovir/therapeutic use; genetic therapy; genetic vectors; humans; mice; mice, inbred c57bl; papillomaviridae/enzymology; papillomaviridae/genetics; papillomaviridae/immunology; thymidine kinase/genetics; thymidine kinase/metabolism; urinary bladder neoplasms/enzymology; urinary bladder neoplasms/genetics; urinary bladder neoplasms/immunology; urinary bladder neoplasms/therapy (1) 1
anti-tumor immunity (1) 1
anticancer properties (1) 1
antigens, neoplasm - immunology (1) 1
antigens, polyomavirus transforming - genetics (1) 1
antigens, polyomavirus transforming - metabolism (1) 1
antitumor immune-responses (1) 1
antiviral agents - therapeutic use (1) 1
anti‐tumor immunity (1) 1
apoptosis - drug effects (1) 1
apoptotic cells (1) 1
article (1) 1
atp secretion (1) 1
autochthonous tumor (1) 1
bilamellar invaginated vesicles (1) 1
biochemistry & molecular biology (1) 1
biology (1) 1
biomarkers, tumor - analysis (1) 1
bladder cancer (1) 1
blood group antigen (1) 1
blood group antigens - immunology (1) 1
blood group antigens - pharmacology (1) 1
breast neoplasms - blood (1) 1
breast neoplasms - immunology (1) 1
breast neoplasms - prevention & control (1) 1
breast-cancer (1) 1
calreticulin exposure (1) 1
cancer gene-therapy (1) 1
cancer research (1) 1
cancer therapy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Molecular Sciences, ISSN 1661-6596, 07/2016, Volume 17, Issue 7, pp. 1125 - 1125
Journal Article
OncoImmunology, ISSN 2162-4011, 06/2013, Volume 2, Issue 6, pp. e24612 - e24612
Oncolytic virotherapy is emerging as a promising approach for the treatment of several neoplasms. The term "oncolytic viruses" is generally employed to... 
reolysin | JX594 | HSV | GM-CSF | talimogene laherparepvec | immunotherapy | Talimogene laherparepvec | Reolysin | Immunotherapy | IMMUNOGENIC CELL-DEATH | SEMLIKI-FOREST-VIRUS | TUMOR-CELLS | IMMUNOLOGY | NEWCASTLE-DISEASE VIRUS | SUICIDE GENE-THERAPY | HERPES-SIMPLEX-VIRUS | ONCOLOGY | PHASE-I TRIAL | RECURRENT HEAD | VESICULAR STOMATITIS-VIRUS | REPLICATING ADENOVIRUS | Review
Journal Article
Molecular Therapy, ISSN 1525-0016, 11/2002, Volume 6, Issue 5, pp. 627 - 636
Gene therapy for cancer using suicide genes such as the herpes simplex virus thymidine kinase gene (HSVtk) has been explored extensively in preclinical and... 
Non-immunogenic | Cytokines | Adenovirus | GM-CSF | Immunotherapy | IL-2 | Gene therapy | 4TI mammary tumor | Cytotoxic T lymphocytes | HSVtk suicide gene
Journal Article
Journal Article
Journal Article
International Journal of Cancer, ISSN 0020-7136, 12/2017, Volume 141, Issue 12, pp. 2551 - 2561
Journal Article
Oncolytic virotherapy, ISSN 2253-1572, 2016, Volume 5, Issue Issue 1, pp. 1 - 13
Oncolytic viruses are multifunctional anticancer agents with huge clinical potential, and have recently passed the randomized Phase III clinical trial hurdle.... 
Chemotherapy | Immunotherapy | Patient outcomes | Methods | Cancer | Medical research | Kinases | Lymphocytes | Cancer therapies | Apoptosis | Oncolytic virotherapy | chemotherapy | immunogenic cell death
Journal Article
Expert Opinion on Biological Therapy, ISSN 1471-2598, 11/2018, Volume 18, Issue 11, pp. 1159 - 1170
Introduction: Conventional therapies for glioblastoma  (GBM) typically fail to provide lasting antitumor benefits, owing to their inability to specifically... 
vaccine | GBM | immunogenic | oncolytic | Glioblastoma | immunotherapy | MEDICINE, RESEARCH & EXPERIMENTAL | NERVOUS-SYSTEM | DENDRITIC CELLS | FACTOR RECEPTOR COMMON | PEPTIDE VACCINATION | TUMOR-CELLS | HUMAN GLIOMA | ADJUVANT TEMOZOLOMIDE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | HUMAN CYTOMEGALOVIRUS-INFECTION | REGULATORY T-CELLS | GENE-THERAPY | Index Medicus
Journal Article
03/2003, ISBN 9780471434795, 15
Liposomes provide efficient delivery of therapeutic agents that can be repeatedly administered, are non‐immunogenic, can penetrate beyond tight barriers to... 
non‐viral delivery | gene delivery | cell entry | extravasation | targeting | liposomes | systemic therapeutics | gene therapy | non‐immunogenic | bilamellar invaginated vesicles (BIV)
Book Chapter